Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Photodynamic therapy in chronic central serous chorioretinopathy.

× No keyword cloud information.

25 in total

1. Effects of photodynamic therapy with verteporfin for the treatment of chronic central serous chorioretinopathy: An uncontrolled, open-label, observational study.

Authors: Yildirim Bayezit Sakalar; Ugur Keklikci; Kaan Unlu; Mehmet Fuat Alakus; Ismail Hamdi Kara
Journal: Curr Ther Res Clin Exp Date: 2010-06

2. A pilot study of intravitreal bevacizumab for the treatment of central serous chorioretinopathy (case reports).

Authors: Mitzy E Torres-Soriano; Gerardo García-Aguirre; Verónica Kon-Jara; Orlando Ustariz-Gonzáles; Maura Abraham-Marín; Michael D Ober; Hugo Quiroz-Mercado
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2008-06-04 Impact factor: 3.117

3. Transpupillary thermotherapy for chronic central serous chorioretinopathy.

Authors: Nazimul Hussain; Rohit Khanna; Anjli Hussain; Taraprasad Das
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2006-01-13 Impact factor: 3.117

4. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy.

Authors: Andrea Russo; Raffaele Turano; Francesco Morescalchi; Elena Gambicorti; Anna Cancarini; Sarah Duse; Ciro Costagliola; Francesco Semeraro
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2017-03-10 Impact factor: 3.117

Review 5. Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors: Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal: Surv Ophthalmol Date: 2013 Mar-Apr Impact factor: 6.048

Review 6. Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis.

Authors: H Q Lu; E Q Wang; T Zhang; Y X Chen
Journal: Eye (Lond) Date: 2015-10-30 Impact factor: 3.775

7. Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up.

Authors: J Fernando Arevalo; Juan V Espinoza
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-03-30 Impact factor: 3.117

Review 8. [Statement and recommendation of the Professional Association of German Ophthalmologists (BVA), the German Ophthalmological Society (DOG) and the German Retina Society (RG) on central serous chorioretinopathy : Situation January 2018].

Authors:
Journal: Ophthalmologe Date: 2018-05 Impact factor: 1.059

9. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression.

Authors: T Leslie; N Lois; D Christopoulou; J A Olson; J V Forrester
Journal: Br J Ophthalmol Date: 2005-02 Impact factor: 4.638

10. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.

Authors: Jun Woong Moon; Hyeong Gon Yu; Tae Wan Kim; Hyung Chan Kim; Hum Chung
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2009-05-07 Impact factor: 3.117